Kadmon Holdings Inc (NASDAQ:KDMN) CEO Harlan Waksal bought 2,000 shares of Kadmon Holdings stock in a transaction dated Wednesday, November 16th. The stock was acquired at an average price of $6.37 per share, with a total value of $12,740.00. Following the acquisition, the chief executive officer now directly owns 102,040 shares of the company’s stock, valued at $649,994.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Harlan Waksal also recently made the following trade(s):

  • On Monday, November 14th, Harlan Waksal bought 2,000 shares of Kadmon Holdings stock. The stock was acquired at an average price of $6.79 per share, with a total value of $13,580.00.

Shares of Kadmon Holdings Inc (NASDAQ:KDMN) traded down 4.24% during mid-day trading on Wednesday, hitting $6.10. The company had a trading volume of 45,377 shares. Kadmon Holdings Inc has a one year low of $4.44 and a one year high of $10.48. The firm’s 50-day moving average price is $6.20 and its 200 day moving average price is $7.82. The company’s market capitalization is $274.98 million.

Kadmon Holdings (NASDAQ:KDMN) last released its earnings results on Wednesday, November 9th. The company reported ($4.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.40) by $3.83. The business had revenue of $5.70 million for the quarter, compared to analysts’ expectations of $3.90 million. Kadmon Holdings’s revenue for the quarter was down 49.6% on a year-over-year basis. Analysts predict that Kadmon Holdings Inc will post ($10.63) earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Kadmon Holdings (NASDAQ:KDMN)

Hedge funds have recently added to or reduced their stakes in the company. KCG Holdings Inc. acquired a new stake in Kadmon Holdings during the third quarter worth approximately $102,000. California State Teachers Retirement System purchased a new position in shares of Kadmon Holdings during the third quarter valued at about $126,000. BlackRock Institutional Trust Company N.A. purchased a new position in shares of Kadmon Holdings during the third quarter valued at about $129,000. Omega Advisors Inc. purchased a new position in shares of Kadmon Holdings during the third quarter valued at about $679,000. Finally, Beach Point Capital Management LP purchased a new position in shares of Kadmon Holdings during the third quarter valued at about $1,480,000.

A number of analysts have recently issued reports on the company. HC Wainwright assumed coverage on Kadmon Holdings in a report on Monday, August 22nd. They issued a “buy” rating and a $25.00 target price for the company. Jefferies Group assumed coverage on Kadmon Holdings in a report on Monday, August 22nd. They issued a “buy” rating and a $12.00 target price for the company. Citigroup Inc. assumed coverage on Kadmon Holdings in a report on Monday, August 22nd. They issued a “neutral” rating and a $12.00 target price for the company. JMP Securities initiated coverage on Kadmon Holdings in a report on Monday, August 22nd. They issued an “outperform” rating and a $16.00 target price for the company. Finally, WBB Securities initiated coverage on Kadmon Holdings in a report on Monday, August 1st. They set a “sell” rating and a $7.50 price objective for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $14.10.

Kadmon Holdings Company Profile

Kadmon Holdings, Inc, formerly Kadmon Holdings, LLC, is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of small molecules and biologics. The Company is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases.

5 Day Chart for NASDAQ:KDMN

Receive News & Stock Ratings for Kadmon Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon Holdings Inc and related stocks with our FREE daily email newsletter.